Skip to main content

Table 3 Correlations between LBP and sCD14 and metabolic and inflammatory variables in the total population and in subjects with MetS

From: Markers of metabolic endotoxemia as related to metabolic syndrome in an elderly male population at high cardiovascular risk: a cross-sectional study

  In the total population (n = 482) In subjects with MetS (n = 182)
LBP sCD14 LBP sCD14
r p r p r p r p
BMI 0.05 0.33 − 0.04 0.34 − 0.06 0.04 0.03 0.70
Waist circumference 0.11 0.02 − 0.01 0.89 0.01 0.95 0.13 0.10
Triglycerides − 0.03 0.56 0.01 0.84 − 0.01 0.86 0.15 0.04
HDL cholesterol − 0.04 0.37 0.02 0.62 − 0.08 0.31 − 0.11 0.15
Systolic blood pressure 0.01 0.78 0.01 0.87 − 0.05 0.51 0.02 0.80
Diastolic blood pressure 0.04 0.36 0.12 0.01 − 0.02 0.79 0.07 0.37
Fasting glucose 0.001 0.96 0.01 0.80 − 0.01 0.93 0.10 0.18
Insulin 0.10 0.04 0.02 0.74 0.13 0.08 0.02 0.75
HOMA 0.08 0.11 0.03 0.59 0.10 0.18 0.07 0.39
TG/HDL ratio − 0.01 0.82 0.01 0.86 0.02 0.80 0.15 0.04
CRP 0.22 < 0.001 0.14 0.003 0.17 0.03 0.09 0.23
IL-6 0.23 < 0.001 0.16 < 0.001 0.2 0.001 0.17 0.02
IL-18 0.15 0.001 0.18 < 0.001 0.17 0.02 0.26 < 0.001
TNFα 0.15 0.001 0.10 0.04 0.24 0.001 0.06 0.39
  1. For abbreviations, see text. Italic text indicates p-values below < 0.05. Subjects with MetS, refers to subjects with 3 out of 5 or more MetS criteria according to the NCEP ATP III definition